Introduction: Induction of labor is commonly practiced intervention in modern Obstetrics. The aim of induction of labor is to initiate labor when maternal and fetal conditions necessitate delivery before the onset of spontaneous contraction with purpose to achieve safe vaginal delivery. Induction of labor is one of the most commonly practiced interventions in the Department of Obstetrics and Gynecology every day. The success of this obstetric practice is highly dependent upon the condition of the cervix which is assessed with Bishop"s Score and it is well known that unfavorable cervix is associated with failure of induction and cesarean section. In the recent years, there has been a considerable interest in the use of nitrous oxide donors for cervical ripening and labor induction. Objective: To evaluate whether isosorbide mononitrate administered vaginally prior to induction in postdated pregnancy is effective for pre-induction cervical ripening and thus, improves the process of induction of labor. Methods: One hundred and twenty women scheduled for labor induction were recruited and assigned randomly to isosorbide mononitrate or placebo followed by misoprostol 25µg. The efficacy of the medication was evaluated by predetermined outcome variables for cervical ripening and induction of labor and delivery. Results: The groups were comparable with respect to age, gestational age and Bishop"s score. Women receiving isosorbide with misoprostol didn"t show any improvement in the Bishop"s score compared to misoprostol and placebo. There was no significant difference between the two groups regarding time of delivery and onset of active stage of labor from induction. Cesarean delivery rates were similar between the two groups; however, the indications of the cesarean section were different between the two groups which were significant statistically. Neonatal outcome were similar between the two groups. Conclusion: The addition of vaginal isosorbide mononitrate to oral misoprostol for cervical ripening and labor induction did not reduce time to vaginal delivery and didn"t help in improving pre-induction cervical score.
Introduction
Induction of labor is an intervention to expedite delivery when there is concern about pregnancy and is usually performed when the benefits to the mother outweighs the risk of continuing pregnancy. Since the late 1960"s prostaglandins have been used for the induction of labor at term, and their analogs have been administered by various routes to induce labor with mostly comparable results. 1 Although several other agents have been proposed to be useful in inducing labor and cervical ripening like: oxytocin, corticosteroids, estrogen, relaxin and nitricoxide donors (NOD), 1, 2 the standardized cervical priming and induction of labor is predominantly achieved by means of Prostaglandins administration. However, in the last years, there has been a considerable interest in the use of misoprostol 3-5 and NOD 6,7 for cervical ripening and labor induction. NOD have been shown to stimulate prostaglandin production in the human cervix after topical administration. So, a total number of 120 women scheduled for labor induction were recruited in this study. Sixty patients were recruited in misoprostol group and 60 patients were recruited as control group received pyridoxine.
Inclusion Criteria  Nulliparity

 Postdated pregnancy (> 41 weeks)
Exclusion Criteria  Pre labor rupture of membrane
The study took place in the Antenatal ward of Department of Obstetrics and Gynecology at BPKIHS. All the patients who were eligible for the study on the basis of inclusion criteria were enrolled in the study.
All the participants were fully informed about the nature and scope as well as potential risk of the study. After consenting for the study, patients were randomized according to computer generated random number There were no significant differences in the incidence of maternal adverse effects.
No significant differences were found in the incidence of cesarean delivery in the two groups. However, regarding indications of cesarean section, fetal distress and meconium stained liquor were more common in isosorbide group and failed induction was more common in placebo group which was statistically significant (P= 0.013). There was no statistical difference between the neonatal outcomes and neonatal Intensive care admission between the two groups. Recently nitric oxide donors such as isosorbide mononitrate have been shown to stimulate prostaglandin production in the human cervix after topical administration.
Discussion
8 Therefore, a combination of both should accelerate the process of cervical ripening and labor induction and possibly potentiate the efficacy of each agent alone without major maternal and fetal adverse effects. The study was conducted to find out whether the addition of isosorbide to the routine administration of misoprostol is more efficient for cervical ripening than misoprostol alone in our setup.
The present study was a randomized controlled trial. One hundred and twenty patients were enrolled in the study and randomized into isosorbide and placebo groups. All subjects in the study received the assigned treatment. All of the 120 patients completed the study. 
Conclusion
In conclusion, the present study shows that addition of nitric oxide donor like Isosorbide mononitrate to misoprostol for pre-induction cervical ripening has no advantage of improving cervical findings in terms of Bishop"s score and neither does it helps in reducing induction to delivery time, suggesting a limited role for isosorbide mononitrate in in-patient cervical ripening and labor induction.
